Article

New acquisition : MImAbs & Beacon®

Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofluidic System for Antibody Discovery

Read the press release

“We are pleased to be leading the way in antibody discovery with Berkeley Lights”
CEO of Mimabs

Do you have any project? Or question?

Contact MimAbs to discuss your project, our team will support you in the scientific study and strategic development planning of your project.

Contact an expert